Cargando…

Efficiency of Ipratropium Bromide and Albuterol Deposition in the Lung Delivered via a Soft Mist Inhaler or Chlorofluorocarbon Metered‐Dose Inhaler

The propellant‐free Combivent Respimat Soft Mist Inhaler (CVT‐R) was developed to replace the chlorofluorocarbon‐propelled Combivent metered‐dose inhaler (CVT‐MDI). This steady‐state pharmacokinetic (PK) substudy evaluated drug lung‐delivery efficiency, using data from two phase III safety and effic...

Descripción completa

Detalles Bibliográficos
Autores principales:	MacGregor, TR, ZuWallack, R, Rubano, V, Castles, MA, Dewberry, H, Ghafouri, M, Wood, CC
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2016
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5351312/ https://www.ncbi.nlm.nih.gov/pubmed/26945929 http://dx.doi.org/10.1111/cts.12387

Ejemplares similares

Efficacy and safety of eco-friendly inhalers: focus on combination ipratropium bromide and albuterol in chronic obstructive pulmonary disease
por: Panos, Ralph J
Publicado: (2013)

COPD patient satisfaction with ipratropium bromide/albuterol delivered via Respimat: a randomized, controlled study
por: Ferguson, Gary T, et al.
Publicado: (2013)

Efficacy and safety of ipratropium bromide/albuterol compared with albuterol in patients with moderate-to-severe asthma: a randomized controlled trial
por: Donohue, James F., et al.
Publicado: (2016)

Efficacy and safety of ipratropium bromide/salbutamol sulphate administered in a hydrofluoroalkane metered-dose inhaler for the treatment of COPD
por: Bhattacharya, Amal, et al.
Publicado: (2016)

Bioequivalence study of ipratropium bromide inhalation aerosol using PBPK modelling
por: Zhang, Jisheng, et al.
Publicado: (2023)

Use of inhaled ipratropium bromide to improve exercise-induced laryngeal obstruction cannot be recommended
por: Muralitharan, Praveen, et al.
Publicado: (2023)

Pharmacokinetic Study of Epinephrine Hydrofluoroalkane (Primatene MIST) Metered-Dose Inhaler
por: Kerwin, Edward M., et al.
Publicado: (2020)

Reduced Environmental Impact of the Reusable Respimat(®) Soft Mist™ Inhaler Compared with Pressurised Metered-Dose Inhalers
por: Hänsel, Michaela, et al.
Publicado: (2019)

Assessment of inhalation flow patterns of soft mist inhaler co-prescribed with dry powder inhaler using inspiratory flow meter for multi inhalation devices
por: Hira, Daiki, et al.
Publicado: (2018)

Inhaler usability of a pressurized metered dose inhaler and a soft mist inhaler in patients with COPD: A simulated-use study
por: Ding, Bo, et al.
Publicado: (2018)

The Effect of Ipratropium Bromide with Violet Flower Extract, Ipratropium Bromide with Budesonide, and Ipratropium Bromide Alone on the Cuff-Leak of the Endotracheal Tube in Intubated ICU Patients
por: Hashemi, Seyed Taghi, et al.
Publicado: (2023)

The Effects of Inhaled Albuterol in Transient Tachypnea of the Newborn
por: Kim, Myo-Jing, et al.
Publicado: (2014)

Bromangiomas-ipratropium bromide–associated angiomas
por: Samlaska, Curt, et al.
Publicado: (2019)

Physicochemical compatibility of fluticasone-17-propionate nebulizer suspension with ipratropium and albuterol nebulizer solutions
por: Kamin, Wolfgang, et al.
Publicado: (2007)

Higher lung deposition with Respimat(®) Soft Mist(™) Inhaler than HFA-MDI in COPD patients with poor technique
por: Brand, Peter, et al.
Publicado: (2008)

Effect of inhaled albuterol on whole blood potassium concentrations in dogs
por: Ogrodny, Andrzej, et al.
Publicado: (2022)

Toxicology of chlorofluorocarbon replacements.
por: Dekant, W
Publicado: (1996)

Aerosol Characteristics and Physico-Chemical Compatibility of Combivent(®) (Containing Salbutamol and Ipratropium Bromide) Mixed with Three Other Inhalants: Budesonide, Beclomethasone or N-Acetylcysteine
por: Zhang, Rui, et al.
Publicado: (2020)

Compound Ipratropium Bromide plus Budesonide Inhalation in the Treatment of Acute Exacerbation of Chronic Obstructive Pulmonary Disease and Its Effect on Heparin-Binding Protein
por: Dong, Yuan, et al.
Publicado: (2022)

Rare causes of anisocoria: Ipratropium bromide and Angel’s trumpet
por: Ekici, Arzu, et al.
Publicado: (2021)

Repeated use of albuterol inhaler as a potential cause of Takotsubo cardiomyopathy
por: Patel, Brijesh, et al.
Publicado: (2014)

Efficacy of Inhaled Levalbuterol Compared to Albuterol in Horses with Recurrent Airway Obstruction
por: Arroyo, M.G., et al.
Publicado: (2016)

Response to first dose of inhaled albuterol in mechanically ventilated preterm infants
por: Raffay, Thomas M., et al.
Publicado: (2021)

Instant velocity and consistency of emitted cloud change by the different levels of canister filling with Metered Dose Inhalers (MDIs), but not with Soft Mist Inhalers (SMIs): a bench study
por: Dal Negro, Roberto W., et al.
Publicado: (2017)

Nebulized albuterol delivery is associated with decreased skeletal muscle strength in comparison with metered‐dose inhaler delivery among children with acute asthma exacerbations
por: Burger, Catherine, et al.
Publicado: (2021)

Use of Respimat(®) Soft Mist™ Inhaler in COPD patients
por: Anderson, Paula
Publicado: (2006)

Transient anisocoria in a patient treated with nebulized ipratropium bromide
por: Pejic, Renato, et al.
Publicado: (2017)

A Dose-Ranging Study of Epinephrine Hydrofluroalkane Metered-Dose Inhaler (Primatene(®) MIST) in Subjects with Intermittent or Mild-to-Moderate Persistent Asthma
por: Kerwin, Edward M., et al.
Publicado: (2020)

Asthma patients prefer Respimat(®) Soft Mist™ Inhaler to Turbuhaler(®)
por: Hodder, Rick, et al.
Publicado: (2009)

Reducing carbon footprint by switching to reusable soft-mist inhalers
por: Janson, Christer, et al.
Publicado: (2023)

Patient preferences for inhaler devices in chronic obstructive pulmonary disease: experience with Respimat(®) Soft Mist(™) Inhaler
por: Hodder, Richard, et al.
Publicado: (2009)

Unilateral mydriasis secondary to ipratropium bromide in a critically ill patient
por: Santana-Cabrera, Luciano, et al.
Publicado: (2012)

Evaluation of inhalational techniques of pressurized metered-dose inhaler with spacer in asthma patients
por: Ravikumar, P, et al.
Publicado: (2018)

The Respimat(®) Soft Mist Inhaler: Implications of Drug Delivery Characteristics for Patients
por: Iwanaga, Takashi, et al.
Publicado: (2019)

Combination of ipratropium bromide and salbutamol in children and adolescents with asthma: A meta-analysis
por: Xu, Hongzhen, et al.
Publicado: (2021)

At home with pulmonary rehabilitation
por: ZuWallack, Richard
Publicado: (2010)

Twelve- and 52-week safety of albuterol multidose dry powder inhaler in patients with persistent asthma
por: Raphael, Gordon, et al.
Publicado: (2016)

Long-term safety of tiotropium delivered by Respimat(®) SoftMist™ Inhaler: patient selection and special considerations
por: Tan, Ching Kuo, et al.
Publicado: (2016)

Development of Respimat(®) Soft Mist™ Inhaler and its clinical utility in respiratory disorders
por: Dalby, Richard N, et al.
Publicado: (2011)

Development and validation of analytical methods for selective determination of albuterol and budesonide in Airsupra inhalation aerosol using spectrophotometry
por: Almalki, Atiah H., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_gronskm5lv96a8iac3ali4kqbu